Free Trial

Corvus Pharmaceuticals (CRVS) Short Interest Ratio & Short Volume

Corvus Pharmaceuticals logo
$3.18 -0.20 (-5.92%)
Closing price 03/31/2025 04:00 PM Eastern
Extended Trading
$3.20 +0.02 (+0.79%)
As of 03/31/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Corvus Pharmaceuticals Short Interest Data

Corvus Pharmaceuticals (CRVS) has a short interest of 5.39 million shares, representing 12.21% of the float (the number of shares available for trading by the public). This marks a 0.75% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.2, indicating that it would take 6.2 days of the average trading volume of 582,090 shares to cover all short positions.

Current Short Interest
5,390,000 shares
Previous Short Interest
5,350,000 shares
Change Vs. Previous Month
+0.75%
Dollar Volume Sold Short
$24.36 million
Short Interest Ratio
6.2 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
64,257,000 shares
Short Percent of Float
12.21%
Today's Trading Volume
933,756 shares
Average Trading Volume
582,090 shares
Today's Volume Vs. Average
160%
Short Selling Corvus Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CRVS Short Interest Over Time

CRVS Days to Cover Over Time

CRVS Percentage of Float Shorted Over Time

Remove Ads

Corvus Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/20255,390,000 shares $24.36 million +0.8%12.2%6.2 $4.52
2/28/20255,350,000 shares $21.61 million -6.6%12.1%5.8 $4.04
2/15/20255,730,000 shares $27.96 million -6.2%13.0%6.2 $4.88
1/31/20256,110,000 shares $32.75 million +11.1%N/A6.2 $5.36
1/15/20255,500,000 shares $27.06 million +1.3%N/A4.9 $4.92
12/31/20245,430,000 shares $29.05 million +26.0%N/A4.7 $5.35
12/15/20244,310,000 shares $31.81 million +22.8%N/A4 $7.38
11/30/20243,510,000 shares $31.91 million +6.4%N/A4.5 $9.09
11/15/20243,300,000 shares $27.03 million +12.6%N/A4.5 $8.19
10/31/20242,930,000 shares $25.90 million +20.1%N/A4.6 $8.84
10/15/20242,440,000 shares $16.40 million +13.5%N/A4.6 $6.72
9/30/20242,150,000 shares $11.35 million +31.1%N/A5.4 $5.28
9/15/20241,640,000 shares $8.36 million +14.7%N/A4.5 $5.10
8/31/20241,430,000 shares $6.41 million +4.4%N/A4.9 $4.48
8/15/20241,370,000 shares $5.21 million +19.1%N/A5.3 $3.80
7/31/20241,150,000 shares $2.96 million -8.0%N/A4.7 $2.57
7/15/20241,250,000 shares $2.50 million -12.6%N/A5.8 $2.00
6/30/20241,430,000 shares $2.60 million -4.7%N/A6.6 $1.82
6/15/20241,500,000 shares $3.06 million -1.3%N/A6.5 $2.04
5/31/20241,520,000 shares $3.28 million +17.8%N/A6.5 $2.16
5/15/20241,290,000 shares $2.86 million -5.2%N/A5.2 $2.22
4/30/20241,360,000 shares $2.11 million -0.7%3.7%5.4 $1.55
4/15/20241,370,000 shares $2.01 million -2.1%3.7%7 $1.47
3/31/20241,400,000 shares $2.49 million -6.0%3.8%6.6 $1.78
3/15/20241,490,000 shares $2.83 million +17.3%4.0%6.8 $1.90
2/29/20241,270,000 shares $2.84 million No Change3.4%5.7 $2.24
2/15/20241,270,000 shares $2.98 million -8.0%3.4%6.2 $2.35
1/31/20241,380,000 shares $2.76 million -1.4%3.7%6.3 $2.00
1/15/20241,400,000 shares $3.28 million +5.3%3.8%6 $2.34
12/31/20231,330,000 shares $2.34 million +2.3%3.6%6.1 $1.76
12/15/20231,300,000 shares $1.99 million -17.2%3.5%6.5 $1.53
11/30/20231,570,000 shares $2.40 million -12.3%4.3%7.9 $1.53
11/15/20231,790,000 shares $2.70 million +4.7%4.9%6.4 $1.51
10/31/20231,710,000 shares $1.93 million -3.4%4.6%6.4 $1.13
10/15/20231,770,000 shares $2.48 million No Change4.8%7.1 $1.40
9/30/20231,770,000 shares $2.58 million -2.8%4.8%6.1 $1.46
9/15/20231,820,000 shares $2.88 million +32.9%4.9%5 $1.58
8/31/20231,370,000 shares $2.90 million +21.2%3.8%2.3 $2.12
8/15/20231,130,000 shares $2.44 million -2.6%3.1%1.8 $2.16
7/31/20231,160,000 shares $2.61 million -17.7%3.4%1.1 $2.25
Trump’s Final Plan (Ad)

Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.

7/15/20231,410,000 shares $3.47 million +11.9%4.1%1.3 $2.46
6/30/20231,260,000 shares $2.89 million +61.4%3.7%1.1 $2.29
6/15/2023780,600 shares $1.94 million -19.8%2.3%0.7 $2.49
5/31/2023973,100 shares $2.96 million +113.6%2.8%1.1 $3.04
5/15/2023455,500 shares $1.18 million +209.2%1.3%0.6 $2.60
4/30/2023147,300 shares $159,084.00 -38.3%0.4%0.6 $1.08
4/15/2023238,700 shares $248,248.00 +50.8%0.7%1.1 $1.04
3/31/2023158,300 shares $144,053.00 -20.9%0.5%0.8 $0.91
3/15/2023200,200 shares $144,144.00 +16.9%0.6%2.1 $0.72
2/28/2023171,200 shares $124,976.00 +35.9%0.5%1.4 $0.73
2/15/2023126,000 shares $97,007.40 +13.7%0.4%1 $0.77
1/31/2023110,800 shares $90,856.00 -34.9%0.3%0.8 $0.82
1/15/2023170,100 shares $154,791.00 -3.7%0.5%1.2 $0.91
12/30/2022176,700 shares $150,195.00 +17.3%0.5%1.2 $0.85
12/15/2022150,600 shares $126,353.40 -53.8%0.4%1 $0.84
11/30/2022325,900 shares $303,803.98 +58.1%0.9%2.2 $0.93
11/15/2022206,100 shares $187,963.20 -0.5%0.6%1.3 $0.91
10/31/2022207,100 shares $179,555.70 -12.4%0.6%1 $0.87
10/15/2022236,500 shares $215,215.00 +16.3%0.7%0.9 $0.91
9/30/2022203,300 shares $166,401.05 +1.6%0.6%0.7 $0.82
9/15/2022200,200 shares $191,191.00 +70.8%0.6%0.6 $0.96
8/31/2022117,200 shares $112,336.20 -64.5%0.3%0.4 $0.96
8/15/2022330,500 shares $371,812.50 -75.2%1.0%1.1 $1.13
7/31/20221,330,000 shares $1.17 million +70.1%3.9%4.7 $0.88
7/15/2022782,000 shares $774,962.00 -15.2%2.3%3.2 $0.99
6/30/2022922,500 shares $913,367.25 +306.2%2.7%3.6 $0.99
6/15/2022227,100 shares $224,806.29 +18.5%0.7%0.9 $0.99
5/31/2022191,600 shares $197,348.00 -22.9%0.6%0.8 $1.03
5/15/2022248,600 shares $258,544.00 +28.6%0.7%1 $1.04
4/30/2022193,300 shares $253,223.00 +5.2%0.6%0.8 $1.31
4/15/2022183,800 shares $266,510.00 -14.9%0.5%0.7 $1.45
3/31/2022215,900 shares $354,076.00 +5.2%0.6%0.7 $1.64
3/15/2022205,200 shares $299,592.00 +3.0%0.6%0.6 $1.46
2/28/2022199,200 shares $352,584.00 -41.3%0.6%0.5 $1.77
2/15/2022339,300 shares $692,172.00 +101.5%1.0%0.7 $2.04
1/31/2022168,400 shares $303,120.00 -43.8%0.5%0.3 $1.80
1/15/2022299,500 shares $673,875.00 +34.0%N/A0 $2.25
12/31/2021223,500 shares $538,635.00 -31.2%0.7%0.3 $2.41
12/15/2021324,700 shares $892,925.00 -43.0%1.0%0.2 $2.75
11/30/2021569,200 shares $1.94 million -45.8%1.9%0.1 $3.41
11/15/20211,050,000 shares $3.89 million -42.9%3.5%0.1 $3.70
10/29/20211,840,000 shares $8.34 million +3.4%6.2%0.2 $4.53
10/15/20211,780,000 shares $8.81 million -42.2%6.3%0.2 $4.95
9/30/20213,080,000 shares $14.91 million +318.7%10.9%0.4 $4.84
9/15/2021735,600 shares $1.68 million +45.0%2.5%0.1 $2.29
8/31/2021507,200 shares $1.15 million -48.0%1.8%2.1 $2.26
8/13/2021975,800 shares $1.93 million -22.6%3.5%4.4 $1.98
7/30/20211,260,000 shares $2.63 million +3.3%4.5%5.3 $2.09
7/15/20211,220,000 shares $2.84 million +0.8%3.7%4.1 $2.33
6/30/20211,210,000 shares $3.23 million +7.1%3.7%4.2 $2.67
Trump’s Final Plan (Ad)

Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.

6/15/20211,130,000 shares $3.10 million -8.9%3.4%3.5 $2.74
5/28/20211,240,000 shares $3.40 million +3.3%3.8%3.4 $2.74
5/14/20211,200,000 shares $2.95 million -9.1%N/A2.1 $2.46
4/30/20211,320,000 shares $3.72 million -1.5%N/A1.4 $2.82
4/15/20211,340,000 shares $3.79 million -7.6%N/A1.5 $2.83
3/31/20211,450,000 shares $4.26 million -8.2%N/A1.6 $2.94
3/15/20211,580,000 shares $5.10 million +24.4%N/A1.8 $3.23
2/26/20211,270,000 shares $4.55 million +2.4%N/A1.5 $3.58
2/12/20211,240,000 shares $4.89 million +0.8%N/A1.8 $3.94
1/29/20211,230,000 shares $4.54 million No Change5.7%5 $3.69
1/15/20211,230,000 shares $5.08 million +2.5%5.7%6.6 $4.13
12/31/20201,200,000 shares $4.52 million -3.2%5.6%6.8 $3.77
12/15/20201,240,000 shares $4.90 million -10.1%5.8%1.5 $3.95
11/30/20201,380,000 shares $5.56 million -0.7%6.4%1.6 $4.03
11/15/20201,390,000 shares $5.74 million -9.2%6.5%1.6 $4.13
10/30/20201,530,000 shares $6.10 million +2.7%7.1%1.7 $3.99
10/15/20201,490,000 shares $5.96 million +8.8%6.9%1.6 $4.00
9/30/20201,370,000 shares $5.49 million -14.4%6.4%1.3 $4.01
9/15/20201,600,000 shares $6.75 million -1.2%7.5%0.8 $4.22
8/31/20201,620,000 shares $6.14 million +2.5%7.6%0.8 $3.79
8/14/20201,580,000 shares $6.35 million -2.5%7.4%0.8 $4.02
7/31/20201,620,000 shares $6.87 million +25.6%7.6%0.8 $4.24
7/15/20201,290,000 shares $4.91 million +204.1%6.0%0.6 $3.81
6/30/2020424,200 shares $1.15 million +0.3%2.1%0.2 $2.72
6/15/2020422,900 shares $1.31 million +29.0%2.1%3.2 $3.10
5/29/2020327,800 shares $1.20 million -72.5%1.7%2.2 $3.66
5/15/20201,190,000 shares $4.18 million -4.0%6.0%7.9 $3.51
4/30/20201,240,000 shares $3.14 million -1.6%5.4%8 $2.53
4/15/20201,260,000 shares $2.94 million No Change4.8%8.3 $2.33

CRVS Short Interest - Frequently Asked Questions

What is Corvus Pharmaceuticals' current short interest?

Short interest is the volume of Corvus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 5,390,000 shares of CRVS short. 12.21% of Corvus Pharmaceuticals' shares are currently sold short. Learn More on Corvus Pharmaceuticals' current short interest.

What is a good short interest ratio for Corvus Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRVS shares currently have a short interest ratio of 6.0. Learn More on Corvus Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Corvus Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corvus Pharmaceuticals: Wolverine Trading LLC, LMR Partners LLP, Group One Trading LLC, Citadel Advisors LLC, Jane Street Group LLC, Boothbay Fund Management LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., and ADAR1 Capital Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Corvus Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.21% of Corvus Pharmaceuticals' floating shares are currently sold short.

Is Corvus Pharmaceuticals' short interest increasing or decreasing?

Corvus Pharmaceuticals saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 5,390,000 shares, an increase of 0.7% from the previous total of 5,350,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Corvus Pharmaceuticals' short interest compare to its competitors?

12.21% of Corvus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Corvus Pharmaceuticals: Day One Biopharmaceuticals, Inc. (22.91%), Avid Bioservices, Inc. (18.17%), Chimerix, Inc. (4.30%), Evolus, Inc. (11.86%), Praxis Precision Medicines, Inc. (10.99%), Avadel Pharmaceuticals plc (10.27%), Replimune Group, Inc. (13.60%), Xencor, Inc. (9.15%), Intellia Therapeutics, Inc. (27.07%), Anavex Life Sciences Corp. (31.75%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Corvus Pharmaceuticals stock?

Short selling CRVS is an investing strategy that aims to generate trading profit from Corvus Pharmaceuticals as its price is falling. CRVS shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Corvus Pharmaceuticals?

A short squeeze for Corvus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRVS, which in turn drives the price of the stock up even further.

How often is Corvus Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRVS, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:CRVS) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners